This post was originally published on this site
Investing.com – Abbott Labs (NYSE:ABT) reported on Wednesday third quarter earnings that beat analysts’ forecasts and revenue that topped expectations.
Abbott Labs announced earnings per share of $1.15 on revenue of $10.40. Analysts polled by Investing.com anticipated EPS of $0.95 on revenue of $9.63B.
Abbott Labs shares are down 25% from the beginning of the year, still down 26.38% from its 52 week high of $142.60 set on December 27, 2021.
Abbott Labs shares gained 0.49% in pre-market trade following the report.
Abbott Labs’s report follows an earnings beat by UnitedHealth on Friday, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
